HK1087015A1 - Composition comprising a mixture of active principles, and method of preparation - Google Patents

Composition comprising a mixture of active principles, and method of preparation

Info

Publication number
HK1087015A1
HK1087015A1 HK06107140.8A HK06107140A HK1087015A1 HK 1087015 A1 HK1087015 A1 HK 1087015A1 HK 06107140 A HK06107140 A HK 06107140A HK 1087015 A1 HK1087015 A1 HK 1087015A1
Authority
HK
Hong Kong
Prior art keywords
mixture
preparation
composition
active principles
principles
Prior art date
Application number
HK06107140.8A
Other languages
English (en)
Inventor
Philippe Chenevier
Dominique Marechal
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of HK1087015A1 publication Critical patent/HK1087015A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer
HK06107140.8A 2003-02-05 2006-06-22 Composition comprising a mixture of active principles, and method of preparation HK1087015A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0301308A FR2850576B1 (fr) 2003-02-05 2003-02-05 Composition comprenant un melange de principes actifs, et procede de preparation
US44719803P 2003-02-13 2003-02-13
PCT/EP2004/050035 WO2004069135A2 (fr) 2003-02-05 2004-01-21 Composition comprenant un melange de principes actifs, et procede pour la preparer

Publications (1)

Publication Number Publication Date
HK1087015A1 true HK1087015A1 (en) 2006-10-06

Family

ID=32852330

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107140.8A HK1087015A1 (en) 2003-02-05 2006-06-22 Composition comprising a mixture of active principles, and method of preparation

Country Status (19)

Country Link
US (2) US7846460B2 (fr)
EP (1) EP1589954B1 (fr)
JP (1) JP4791348B2 (fr)
KR (1) KR20050096963A (fr)
CN (1) CN1747723B (fr)
AU (1) AU2004210438B2 (fr)
BR (1) BRPI0407116B1 (fr)
CA (1) CA2514446C (fr)
EA (1) EA010972B1 (fr)
ES (1) ES2590807T3 (fr)
FR (1) FR2850576B1 (fr)
HK (1) HK1087015A1 (fr)
IL (1) IL169880A (fr)
IS (1) IS7998A (fr)
MX (1) MXPA05008161A (fr)
NO (1) NO341294B1 (fr)
NZ (1) NZ541886A (fr)
PL (1) PL223347B1 (fr)
WO (1) WO2004069135A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI365880B (en) 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
WO2007015243A2 (fr) 2005-08-02 2007-02-08 Sol-Gel Technologies Ltd. Revetement par un oxyde metallique d'ingredients hydroinsolubles
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
US8465776B2 (en) 2006-08-04 2013-06-18 Ethypharm Granule and orally disintegrating tablet comprising oxycodone
KR20090057399A (ko) * 2006-09-26 2009-06-05 노파르티스 아게 Ｓ１ｐ 조정제를 포함하는 제약 조성물
WO2008089774A1 (fr) * 2007-01-22 2008-07-31 Crd Saidal Formulation d'un comprime orodispersible a base de paracetamol enrobe
ES2912051T3 (es) 2007-02-01 2022-05-24 Sol Gel Tech Ltd Composiciones para aplicación tópica que comprenden un peróxido y retinoide
ES2476259T3 (es) * 2007-12-27 2014-07-14 Taiho Pharmaceutical Co., Ltd. Preparación antitumoral de material particulado oral
MX2011011480A (es) * 2009-05-01 2012-02-28 Aptalis Pharmatech Inc Composicines de tabletas que se desintegran oralmente que comprenden combinaciones de analgesicos no opioides y opioides.
CN102526124B (zh) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 一种中药粉体及其制备方法
CN104144681A (zh) * 2012-03-02 2014-11-12 罗德兹制药股份有限公司 抗破坏性立即释放型制剂类
WO2014042120A1 (fr) * 2012-09-13 2014-03-20 ライオン株式会社 Composition orale de formation de mousse, préparation solide orale de formation de mousse et produit oral de formation de mousse
EP2906202A4 (fr) * 2012-10-15 2016-04-27 Isa Odidi Formulations de médicament pour administration par voie orale
KR101484608B1 (ko) * 2012-11-26 2015-01-22 한국과학기술연구원 Pva와 알지네이트 기반 코어-쉘 구조의 복합담체 및 그 제조방법
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
CN111389345A (zh) 2013-02-01 2020-07-10 格雷斯公司 作为用于液体技术的载体的多孔硅胶
WO2015023675A2 (fr) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération immédiate
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2016010771A1 (fr) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
CN111990641A (zh) * 2020-05-06 2020-11-27 焦作百仑斯生物科技有限公司 一种解酒护肝片及施工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044404A (ja) * 1998-07-27 2000-02-15 Otsuka Chem Co Ltd 農業用混合粒剤
CA2259727A1 (fr) * 1999-01-18 2000-07-18 Bernard Charles Sherman Pastille pharmaceutique a deux couches comprenant un ains et du misoprostol
US6451342B2 (en) * 2000-05-01 2002-09-17 Aeropharm Technology Incorporated Core formulation comprised of troglitazone and a biguanide
US6296874B1 (en) * 2000-05-01 2001-10-02 Aeropharm Technology Incorporated Core formulation comprising troglitazone and abiguanide
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
JP4616009B2 (ja) * 2002-12-26 2011-01-19 ポーゼン インコーポレイテッド ＮＳＡＩＤｓおよびトリプタンを含有する多層剤型

Also Published As

Publication number Publication date
KR20050096963A (ko) 2005-10-06
PL223347B1 (pl) 2016-10-31
ES2590807T3 (es) 2016-11-23
JP4791348B2 (ja) 2011-10-12
FR2850576B1 (fr) 2007-03-23
US20110081389A1 (en) 2011-04-07
CN1747723B (zh) 2010-05-12
FR2850576A1 (fr) 2004-08-06
EA010972B1 (ru) 2008-12-30
EP1589954B1 (fr) 2016-08-31
US7846460B2 (en) 2010-12-07
US20060134422A1 (en) 2006-06-22
CA2514446A1 (fr) 2004-08-19
PL376465A1 (en) 2005-12-27
IS7998A (is) 2005-08-25
BRPI0407116A (pt) 2006-01-10
BRPI0407116B1 (pt) 2018-04-03
CN1747723A (zh) 2006-03-15
WO2004069135A3 (fr) 2004-10-28
WO2004069135A2 (fr) 2004-08-19
EP1589954A2 (fr) 2005-11-02
CA2514446C (fr) 2012-04-10
NZ541886A (en) 2008-12-24
JP2006516597A (ja) 2006-07-06
MXPA05008161A (es) 2005-10-05
IL169880A (en) 2013-10-31
EA200501250A1 (ru) 2006-02-24
AU2004210438B2 (en) 2007-08-16
NO341294B1 (no) 2017-10-02
NO20053799L (no) 2005-08-11
AU2004210438A1 (en) 2004-08-19
IL169880A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
HK1087015A1 (en) Composition comprising a mixture of active principles, and method of preparation
PL377161A1 (pl) Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
IL169648A0 (en) Novel structures and method of preparation
IL164703A0 (en) ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
ZA200506790B (en) Arylvinylazacycloalkane compounds and method of preparation and use thereof
AU2003274211A8 (en) Flame-retardant composition, preparation method and use thereof
AU2003248721A1 (en) Adsorbents, methods of preparation, and methods of use thereof
AU2003239614A8 (en) Cardiolipin compositions, methods of preparation and use
IL167187A (en) Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
IL176515A0 (en) 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
AU2003302188A8 (en) Method of obtaining a soothing active ingredient, active ingredient and compositions obtained
PL1778265T3 (pl) Związki guanylohydrazonowe, kompozycje, sposoby wytwarzania i stosowania
AU2003210871A8 (en) Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof
AU2002246950A1 (en) Hydrocapsules and method of preparation
EP1594440A4 (fr) Preparation selective et specifique de composes peg discrets
EP1711490A4 (fr) Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant
IL163596A0 (en) Cd40 splice variants, compositions for making and methods of using thesame
HK1107256A1 (en) Compositions containing nicorandil, preparation method and use
AU2002953252A0 (en) Compositions, Compounds and Methods for their Preparation
IL174081A0 (en) Formulation for obtaining a pharmaceutical composition, methods of obtaining and use thereof
AU2002357561A8 (en) Oxazolidine derivative, methods of preparation and uses
AU2003303815A1 (en) Alanines compounds, method of preparing them and their use
AU2003246840A8 (en) Anti-hiv composition, production method thereof and medicament

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230124